Leo Lens Technology
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
12285 World Trade Dr Ste I, San Diego, C...Phone Number
(858) 385-0800Website
www.leolens.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Leo Lens Technology
Leo Lens Technology (LLT) is an emerging San Diego-based company focused on using its unique platform technology to commercialize a drug-eluting, comfort-enhancing contact lens to treat millions of patients worldwide. While eye drops have been around for over 40 years and remain the standard of care for over 90% of patients, they have only around a 50% compliance rate. This leads millions to suffer from disease progression and thousands to suffer from preventable blindness. There is a large unmet need for a better non-invasive treatment option in this $10B US market. LLT's patented technology offers a unique value proposition for patients, practitioners, strategic partners, and payers. LLT is currently focused on getting its lead asset, a lens to treat glaucoma, to the clinic while continuing to build out its product pipeline. LLT had a successful pre-IND meeting with the FDA to confirm its regulatory strategy and will soon be submitting an IND for the glaucoma product.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Leo Lens Technology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Leo Lens Technology had a recent Job posting/layoffs
Check out if Leo Lens Technology is spiking on competitors!
Product Launch: Get notified when Leo Lens Technology launches new products
Earning: See what the market has to say on Leo Lens Technology recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Leo Lens Technology has new funding data
Check if Leo Lens Technology has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Leo Lens Technology
Leo Lens Technology, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Leo Lens Technology
Find 2 more new buyers
Company Profile Activity
Activity Insights
Leo Lens Technology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Leo Lens Technology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Leo Lens Technology.
Leo Lens Technology financials insights
Gather financial insights about Leo Lens Technology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$96K
Leo Lens Technology Tech Stack
A closer look at the technologies used by Leo Lens Technology
Leo Lens Technology News & Media
Myopia Management Focus of Pipeline Expansion for Leo Lens Pharma
SAN DIEGO--(BUSINESS WIRE)--Myopia Management Focus of Pipeline Expansion for Leo Lens Pharma
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Leo Lens Technology
Sign Up For FreeTo access detailed company insights
Leo Lens Technology (LLT) is an emerging San Diego-based company focused on using its unique platform technology to commercialize a drug-eluting, comfort-enhancing contact lens to treat millions of patients worldwide. While eye drops have been around for over 40 years and remain the standard of care for over 90% of patients, they have only around a... Read More
